Serum Folate by Two Methods in Pregnant Women Carrying Fetuses with Neural Tube Defects
Open Access
- 1 July 2002
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 48 (7) , 1094-1095
- https://doi.org/10.1093/clinchem/48.7.1094
Abstract
Neural tube defects (NTDs) are the most common severe congenital malformations that occur as a result of failure of neural tube closure at the beginning of pregnancy (24–28 days after conception). Genetic (4)(2)(3), environmental (4), and nutritional factors (5)(6)(7)(8)(9) can be involved in the etiology of NTDs.Keywords
This publication has 11 references indexed in Scilit:
- Metabolic effects of C677T and A1298C mutations at the MTHFR gene in Brazilian children with neural tube defectsClinica Chimica Acta; International Journal of Clinical Chemistry, 2001
- A common mutation in the methylenetetrahydrofolate reductase gene is associated with an accumulation of formylated tetrahydrofolates in red blood cellsProceedings of the National Academy of Sciences, 1998
- Decreased methylene tetrahydrofolate reductase activity due to the 677C→T mutation in families with spina bifida offspringJournal of Molecular Medicine, 1996
- Results of an international round robin for serum and whole-blood folateClinical Chemistry, 1996
- Blood folic acid and vitamin B12 in relation to neural tube defectsBJOG: An International Journal of Obstetrics and Gynaecology, 1996
- Folate Levels and Neural Tube DefectsJAMA, 1995
- Periconceptional folate and neural tube defectThe American Journal of Clinical Nutrition, 1994
- Investigation of factors influencing folate status in women who have had a neural tube defect‐affected infantBJOG: An International Journal of Obstetrics and Gynaecology, 1993
- Maternal Heat Exposure and Neural Tube DefectsJAMA, 1992
- Dietary folate as a risk factor for neural‐tube defects: evidence from a case‐control study in Western AustraliaThe Medical Journal of Australia, 1989